- Fragile X
- Treatment & Intervention
- Support the NFXF
Now Recruiting Research Participants: Combining Lovastatin and a Parent-Implemented Language Intervention in a Multimodal Treatment for Fragile X syndrome
We invite you to take part in a research study to test the efficacy of a multimodal treatment comprised of the medication Lovastatin or placebo, and a Parent-Implemented Language Intervention (PILI) in children and adolescents with FXS.
Children and adolescents between the ages of 10-17 diagnosed with Fragile X syndrome. Participants must be able to speak in at least two to three word phrases of English.
To learn more about the LOVA study, please contact:
(916) 703-0491 or email@example.com
(916) 703-0281 or firstname.lastname@example.org
The UC Davis MIND Institute is a collaborative international research center committed to the awareness, understanding, prevention and care of neurodevelopmental disorders.
All studies take place at the MIND Institute, located at 2825 50th St. in Sacramento, CA 95817
For a map and directions, visit mindinstitute.ucdavis.edu.